Tag: Biotechnology

Impact Newswire brings you the latest in Biotechnology news.

AdvanCell
Australia, Global

AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

SYDNEY–(BUSINESS WIRE)–AdvanCell, a clinical-stage radiopharmaceutical company developing a pipeline of Targeted Alpha Therapies for patients with cancer, today announced the appointment of Anna Karmann, MD, PhD as the company’s Chief Medical Officer based in San Francisco. “Anna’s passion, insights, entrepreneurial mindset and expertise are invaluable to AdvanCell as we develop our portfolio of Targeted Alpha Therapies for patients globally.”Post this Dr. Karmann joins from RayzeBio, … Continue reading AdvanCell Appoints Anna Karmann, MD, PhD as Chief Medical Officer

Impact Newswire
Mission Bio
Global, United States

Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Former Fortis Life Sciences CEO and private equity executive to drive expansion into clinical end markets and accelerate strategic biopharma collaborations SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Mission Bio, a leader in single-cell multiomic solutions for precision medicine, announced the appointment of Brian Kim as Chief Executive Officer. With over two decades of experience in the life sciences industry, he brings a unique combination of scientific innovation … Continue reading Mission Bio Appoints Industry Veteran Brian Kim as CEO to Spearhead Single-Cell Genomic Solutions

Impact Newswire
VERNAL BIOSCIENCES
Global, United States

Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation

COLCHESTER, Vt.–(BUSINESS WIRE)–Vernal Biosciences, a leading manufacturing and services company specializing in mRNA and lipid nanoparticle (LNP) formulation, proudly announces the additions of Sven Lee, Chief Commercial Officer, and Richard P. Hamel, Chief Financial Officer to its leadership team. Both distinguished leaders will strengthen Vernal’s position as a premier mRNA and LNP Contract Development and Manufacturing Organization (CDMO) while using their deep experience to deliver … Continue reading Vernal Biosciences Announces Strategic Leadership Appointments to Drive Growth in mRNA and LNP Formulation

Impact Newswire
IEEE
Global, United States

Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief

PISCATAWAY, N.J.–(BUSINESS WIRE)–IEEE, the world’s largest technical professional organization dedicated to advancing technology for humanity, and the IEEE Engineering in Medicine and Biology Society (EMBS), today announced the appointment of biomedical technology veteran Mike Hess as editor-in-chief of IEEE Pulse. “The magazine should be a platform to inform and update the public about advances in the healthcare field, exchange ideas, and share knowledge and data. I … Continue reading Biomedical Technology Veteran Mike Hess Joins IEEE Pulse as Editor-in-Chief

Impact Newswire
Bruker
Global, United States

Bruker Acquires Electron Microscopy Company Nion

High-end STEM Technology Expands Bruker’s Portfolio for Materials Science Research BILLERICA, Mass.–(BUSINESS WIRE)–Bruker today announced that it has acquired Nion, a privately-held company that develops and manufactures innovative high-end scanning transmission electron microscopes (STEM). Nion was the first company to introduce aberration correction for STEM instruments with ultra-high stability for highest resolution images, and Nion is the world leader in ultra-high energy and spatial resolution electron … Continue reading Bruker Acquires Electron Microscopy Company Nion

Impact Newswire
Star Therapeutics
Global, United States

Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Star Therapeutics, a biotechnology company interrogating novel biology to develop life-changing therapies, today announced the appointment of Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer. Mr. Robertson brings more than twenty years of experience with corporate strategy, business operations, capital raising and M&A. “I’m very excited to join the Star Therapeutics team at a time of great momentum … Continue reading Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer

Impact Newswire
1910 GENETICS
Global, United States

1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

Dr. Gandhi is VP and Head of Strategic Partnerships for Pfizer Ignite and will bring clinical, strategic and financial leadership to biotech’s board BOSTON–(BUSINESS WIRE)–1910 Genetics, the only biotech advancing small and large molecule drug discovery with an automated, multimodal AI platform, today announced the appointment of Shaan C. Gandhi, MD, DPhil, to its board of directors. Gandhi joins as an independent board director and … Continue reading 1910 Genetics Appoints Dr. Shaan C. Gandhi as Independent Board Director

Impact Newswire
Amide Technologies
Global, United States

Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery

Spun out of MIT, Amide partners with biopharmas to accelerate peptide drug development – shortening synthesis to days instead of months – with peptides 3x longer than existing methods CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amide Technologies, a biotech that synthesizes challenging peptides, announced today that it has begun commercializing its novel peptide manufacturing platform. The company also announced it has raised $16.5 million in total funding to date, … Continue reading Amide Technologies Announces Complex Peptide Manufacturing Platform, Raises $16.5M to Expedite Frontier Drug Discovery

Impact Newswire
Abcuro
Global, United States

Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors

December 06, 2023 07:00 AM Eastern Standard Time NEWTON, Mass.–(BUSINESS WIRE)–Abcuro, Inc., a clinical-stage biotechnology company developing therapies for the treatment of autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells, today announced the appointment of Mark Pruzanski, M.D., as Chairman of its Board of Directors. Dr. Pruzanski brings more than 30 years of experience as a life sciences executive, entrepreneur … Continue reading Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors

Impact Newswire